MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Selecta Biosciences, Inc. (NASDAQ:SELB)
Organization & Developments: Selecta
Parents
Selecta Biosciences, Inc. (NASDAQ:SELB)
Children
*Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.
2011: The Juvenile Diabetes Research Foundation and Selecta Biosciences, Inc. Enter Research Collaboration for Vaccines for Type 1 Diabetes (2011)
2018: Is The Worst Yet To Come For Selecta Biosciences?seekingalpha.com
2018: The Investment Case For Selecta Biosciences - Selecta Biosciences (NASDAQ:SELB)
2019: Selecta Biosciences Is Worth A Look After Restructuring_seekingalpha.com
2020: Stock Doctor: Selecta Biosciences Continues To Attract Partners As Sarepta Therapeutics Signs On For Gene Therapy
2020: It's Time To Invest In Selecta Biosciences As They Ink Massive $100 Million Upfront Deal
2020: Selecta: ImmTOR Platform's Potential In Key
2021: Sizing Up Selecta Biosciences
2023: Selecta lays off 25% as unpartnered gene therapies take a back seat
Jumps
*Key People: Selecta
Finance & Acquisitions: Selecta